1. Market Overview of Non-small Cell Lung Cancer
1.1 Non-small Cell Lung Cancer Market Overview
1.1.1 Non-small Cell Lung Cancer Product Scope
1.1.2 Market Status and Outlook
1.2 Non-small Cell Lung Cancer Market Size by Regions: 2015 VS 2021 VS 2026
1.3 Non-small Cell Lung Cancer Historic Market Size by Regions (2015-2020)
1.4 Non-small Cell Lung Cancer Forecasted Market Size by Regions (2021-2026)
1.5 Covid-19 Impact on Key Regions, Keyword Market Size YoY Growth (2015-2026)
1.5.1 North America
1.5.2 East Asia
1.5.3 Europe
1.5.4 South Asia
1.5.5 Southeast Asia
1.5.6 Middle East
1.5.7 Africa
1.5.8 Oceania
1.5.9 South America
1.5.10 Rest of the World
1.6 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.6.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.6.2 Covid-19 Impact: Commodity Prices Indices
1.6.3 Covid-19 Impact: Global Major Government Policy
2. Covid-19 Impact Non-small Cell Lung Cancer Sales Market by Type (2015-2026)
2.1 Global Non-small Cell Lung Cancer Historic Market Size by Type (2015-2020)
2.2 Global Non-small Cell Lung Cancer Forecasted Market Size by Type (2021-2026)
2.3 Surgery
2.4 Radiofrequency ablation (RFA)
2.5 Radiation therapy
2.6 Chemotherapy
2.7 Targeted therapies
2.8 Immunotherapy
3. Covid-19 Impact Non-small Cell Lung Cancer Sales Market by Application (2015-2026)
3.1 Global Non-small Cell Lung Cancer Historic Market Size by Application (2015-2020)
3.2 Global Non-small Cell Lung Cancer Forecasted Market Size by Application (2021-2026)
3.3 Application 1
3.4 Application 2
3.5 Other
4. Covid-19 Impact Market Competition by Manufacturers
4.1 Global Non-small Cell Lung Cancer Production Capacity Market Share by Manufacturers (2015-2020)
4.2 Global Non-small Cell Lung Cancer Revenue Market Share by Manufacturers (2015-2020)
4.3 Global Non-small Cell Lung Cancer Average Price by Manufacturers (2015-2020)
5. Company Profiles and Key Figures in Non-small Cell Lung Cancer Business
5.1 Bristol-Myers Squibb
5.1.1 Bristol-Myers Squibb Company Profile
5.1.2 Bristol-Myers Squibb Non-small Cell Lung Cancer Product Specification
5.1.3 Bristol-Myers Squibb Non-small Cell Lung Cancer Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.2 GlaxoSmithKline
5.2.1 GlaxoSmithKline Company Profile
5.2.2 GlaxoSmithKline Non-small Cell Lung Cancer Product Specification
5.2.3 GlaxoSmithKline Non-small Cell Lung Cancer Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.3 Sanofi
5.3.1 Sanofi Company Profile
5.3.2 Sanofi Non-small Cell Lung Cancer Product Specification
5.3.3 Sanofi Non-small Cell Lung Cancer Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.4 ZIOPHARM Oncology
5.4.1 ZIOPHARM Oncology Company Profile
5.4.2 ZIOPHARM Oncology Non-small Cell Lung Cancer Product Specification
5.4.3 ZIOPHARM Oncology Non-small Cell Lung Cancer Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.5 Alchemia
5.5.1 Alchemia Company Profile
5.5.2 Alchemia Non-small Cell Lung Cancer Product Specification
5.5.3 Alchemia Non-small Cell Lung Cancer Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.6 Amgen
5.6.1 Amgen Company Profile
5.6.2 Amgen Non-small Cell Lung Cancer Product Specification
5.6.3 Amgen Non-small Cell Lung Cancer Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.7 Apotex
5.7.1 Apotex Company Profile
5.7.2 Apotex Non-small Cell Lung Cancer Product Specification
5.7.3 Apotex Non-small Cell Lung Cancer Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.8 BioMarin Pharmaceutical
5.8.1 BioMarin Pharmaceutical Company Profile
5.8.2 BioMarin Pharmaceutical Non-small Cell Lung Cancer Product Specification
5.8.3 BioMarin Pharmaceutical Non-small Cell Lung Cancer Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.9 CellAct Pharma
5.9.1 CellAct Pharma Company Profile
5.9.2 CellAct Pharma Non-small Cell Lung Cancer Product Specification
5.9.3 CellAct Pharma Non-small Cell Lung Cancer Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.10 Menarini
5.10.1 Menarini Company Profile
5.10.2 Menarini Non-small Cell Lung Cancer Product Specification
5.10.3 Menarini Non-small Cell Lung Cancer Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.11 Cerulean Pharma
5.11.1 Cerulean Pharma Company Profile
5.11.2 Cerulean Pharma Non-small Cell Lung Cancer Product Specification
5.11.3 Cerulean Pharma Non-small Cell Lung Cancer Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.12 Cipla
5.12.1 Cipla Company Profile
5.12.2 Cipla Non-small Cell Lung Cancer Product Specification
5.12.3 Cipla Non-small Cell Lung Cancer Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.13 Cornerstone Pharmaceuticals
5.13.1 Cornerstone Pharmaceuticals Company Profile
5.13.2 Cornerstone Pharmaceuticals Non-small Cell Lung Cancer Product Specification
5.13.3 Cornerstone Pharmaceuticals Non-small Cell Lung Cancer Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.14 Curis
5.14.1 Curis Company Profile
5.14.2 Curis Non-small Cell Lung Cancer Product Specification
5.14.3 Curis Non-small Cell Lung Cancer Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.15 CytRx
5.15.1 CytRx Company Profile
5.15.2 CytRx Non-small Cell Lung Cancer Product Specification
5.15.3 CytRx Non-small Cell Lung Cancer Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.16 Eli Lilly
5.16.1 Eli Lilly Company Profile
5.16.2 Eli Lilly Non-small Cell Lung Cancer Product Specification
5.16.3 Eli Lilly Non-small Cell Lung Cancer Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.17 Exelixis
5.17.1 Exelixis Company Profile
5.17.2 Exelixis Non-small Cell Lung Cancer Product Specification
5.17.3 Exelixis Non-small Cell Lung Cancer Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.18 Fresenius Kabi
5.18.1 Fresenius Kabi Company Profile
5.18.2 Fresenius Kabi Non-small Cell Lung Cancer Product Specification
5.18.3 Fresenius Kabi Non-small Cell Lung Cancer Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.19 Genentech
5.19.1 Genentech Company Profile
5.19.2 Genentech Non-small Cell Lung Cancer Product Specification
5.19.3 Genentech Non-small Cell Lung Cancer Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.20 Hikma Pharmaceuticals
5.20.1 Hikma Pharmaceuticals Company Profile
5.20.2 Hikma Pharmaceuticals Non-small Cell Lung Cancer Product Specification
5.20.3 Hikma Pharmaceuticals Non-small Cell Lung Cancer Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.21 Hospira
5.21.1 Hospira Company Profile
5.21.2 Hospira Non-small Cell Lung Cancer Product Specification
5.21.3 Hospira Non-small Cell Lung Cancer Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.22 Intas Pharmaceuticals
5.22.1 Intas Pharmaceuticals Company Profile
5.22.2 Intas Pharmaceuticals Non-small Cell Lung Cancer Product Specification
5.22.3 Intas Pharmaceuticals Non-small Cell Lung Cancer Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.23 Karyopharm Therapeutics
5.23.1 Karyopharm Therapeutics Company Profile
5.23.2 Karyopharm Therapeutics Non-small Cell Lung Cancer Product Specification
5.23.3 Karyopharm Therapeutics Non-small Cell Lung Cancer Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.24 Kyowa Hakko Kirin
5.24.1 Kyowa Hakko Kirin Company Profile
5.24.2 Kyowa Hakko Kirin Non-small Cell Lung Cancer Product Specification
5.24.3 Kyowa Hakko Kirin Non-small Cell Lung Cancer Production Capacity, Revenue, Price and Gross Margin (2015-2020)
6. North America
6.1 North America Non-small Cell Lung Cancer Market Size (2015-2026)
6.2 North America Non-small Cell Lung Cancer Key Players in North America (2015-2020)
6.3 North America Non-small Cell Lung Cancer Market Size by Type (2015-2020)
6.4 North America Non-small Cell Lung Cancer Market Size by Application (2015-2020)
7. East Asia
7.1 East Asia Non-small Cell Lung Cancer Market Size (2015-2026)
7.2 East Asia Non-small Cell Lung Cancer Key Players in North America (2015-2020)
7.3 East Asia Non-small Cell Lung Cancer Market Size by Type (2015-2020)
7.4 East Asia Non-small Cell Lung Cancer Market Size by Application (2015-2020)
8. Europe
8.1 Europe Non-small Cell Lung Cancer Market Size (2015-2026)
8.2 Europe Non-small Cell Lung Cancer Key Players in North America (2015-2020)
8.3 Europe Non-small Cell Lung Cancer Market Size by Type (2015-2020)
8.4 Europe Non-small Cell Lung Cancer Market Size by Application (2015-2020)
9. South Asia
9.1 South Asia Non-small Cell Lung Cancer Market Size (2015-2026)
9.2 South Asia Non-small Cell Lung Cancer Key Players in North America (2015-2020)
9.3 South Asia Non-small Cell Lung Cancer Market Size by Type (2015-2020)
9.4 South Asia Non-small Cell Lung Cancer Market Size by Application (2015-2020)
10. Southeast Asia
10.1 Southeast Asia Non-small Cell Lung Cancer Market Size (2015-2026)
10.2 Southeast Asia Non-small Cell Lung Cancer Key Players in North America (2015-2020)
10.3 Southeast Asia Non-small Cell Lung Cancer Market Size by Type (2015-2020)
10.4 Southeast Asia Non-small Cell Lung Cancer Market Size by Application (2015-2020)
11. Middle East
11.1 Middle East Non-small Cell Lung Cancer Market Size (2015-2026)
11.2 Middle East Non-small Cell Lung Cancer Key Players in North America (2015-2020)
11.3 Middle East Non-small Cell Lung Cancer Market Size by Type (2015-2020)
11.4 Middle East Non-small Cell Lung Cancer Market Size by Application (2015-2020)
12. Africa
12.1 Africa Non-small Cell Lung Cancer Market Size (2015-2026)
12.2 Africa Non-small Cell Lung Cancer Key Players in North America (2015-2020)
12.3 Africa Non-small Cell Lung Cancer Market Size by Type (2015-2020)
12.4 Africa Non-small Cell Lung Cancer Market Size by Application (2015-2020)
13. Oceania
13.1 Oceania Non-small Cell Lung Cancer Market Size (2015-2026)
13.2 Oceania Non-small Cell Lung Cancer Key Players in North America (2015-2020)
13.3 Oceania Non-small Cell Lung Cancer Market Size by Type (2015-2020)
13.4 Oceania Non-small Cell Lung Cancer Market Size by Application (2015-2020)
14. South America
14.1 South America Non-small Cell Lung Cancer Market Size (2015-2026)
14.2 South America Non-small Cell Lung Cancer Key Players in North America (2015-2020)
14.3 South America Non-small Cell Lung Cancer Market Size by Type (2015-2020)
14.4 South America Non-small Cell Lung Cancer Market Size by Application (2015-2020)
15. Rest of the World
15.1 Rest of the World Non-small Cell Lung Cancer Market Size (2015-2026)
15.2 Rest of the World Non-small Cell Lung Cancer Key Players in North America (2015-2020)
15.3 Rest of the World Non-small Cell Lung Cancer Market Size by Type (2015-2020)
15.4 Rest of the World Non-small Cell Lung Cancer Market Size by Application (2015-2020)
16 Non-small Cell Lung Cancer Market Dynamics
16.1 Covid-19 Impact Market Top Trends
16.2 Covid-19 Impact Market Drivers
16.3 Covid-19 Impact Market Challenges
16.4 Porters Five Forces Analysis
18 Regulatory Information
17 Analyst's Viewpoints/Conclusions
18 Appendix
18.1 Research Methodology
18.1.1 Methodology/Research Approach
18.1.2 Data Source
18.2 Disclaimer

Menu 2

Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium, totam rem aperiam.